Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis

Judith A Van de Water, Lauren B. Gerson, Linda D. Ferrell, John R. Lake, Ross L. Coppel, Kenneth P. Batts, Russell H. Wiesner, M. Eric Gershwin

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Whether primary biliary cirrhosis (PBC) recurs after liver transplantation has remained an interesting and controversial issue; rejection, viral hepatitis, and drug effects all may mimic recurrent PBC histologically and biochemically. Furthermore, reliable clinical criteria for PBC recurrence are lacking. In this study, the issue of disease recurrence using a well-characterized monoclonal antibody (MAb), C355.1, that reacts with the immunodominant mitochondrial autoantigen of PBC (pyruvate dehydrogenase complex [PDC-E2]) was addressed. When used in an immunohistochemical assay, C355.1 produces intense apical staining of bile duct epithelium specifically in liver sections of patients with PBC and may be the earliest known marker of PBC. Immunohistochemical and histological analysis of serial liver biopsy specimens of 67 patients pre- and post- orthotopic liver transplantation (OLT), including 38 patients with PBC and 29 non-PBC liver disease controls, was performed. Sections were stained with MAb C355.1 or the control MAb C315 and analyzed to determine whether there was a recurrence of apical reactivity in the bile ducts of the posttransplantation biopsy specimens. The immunohistochemical staining was correlated with the histological findings and serum biochemistries at the time of the biopsy. Our data indicate that a significant number of patients who underwent transplantation for PBC (28 of 38) but not controls (0 of 29) develop a staining pattern of liver bile duct epithelium with MAb C355.1 that is indistinguishable from the pretransplantation pattern. Of the 28 patients with this apical staining pattern, 8 were characterized histologically as possible recurrent PBC, 2 as chronic rejection, 2 as acute rejection, 9 as nonspecific changes, 4 as normal or near normal, and 3 had other histological changes. Only 50% of the patients with apical C355.1 staining had liver enzyme levels suggestive of cholestasis. Thus, there appears to be immunohistochemical evidence that supports the concept of recurrence of PBC after OLT. The appearance of biliary epithelial abnormalities before the clinical appearance of disease is important not only for liver transplantation but also for understanding the natural history of PBC.

Original languageEnglish (US)
Pages (from-to)1079-1084
Number of pages6
JournalHepatology
Volume24
Issue number5
DOIs
StatePublished - Nov 1996

Fingerprint

Biliary Liver Cirrhosis
Liver Transplantation
Recurrence
Staining and Labeling
Bile Ducts
Monoclonal Antibodies
Liver
Biopsy
Dihydrolipoyllysine-Residue Acetyltransferase
Epithelium
Cholestasis
Autoantigens
Biochemistry
Hepatitis
Liver Diseases
Transplantation

ASJC Scopus subject areas

  • Hepatology

Cite this

Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. / Van de Water, Judith A; Gerson, Lauren B.; Ferrell, Linda D.; Lake, John R.; Coppel, Ross L.; Batts, Kenneth P.; Wiesner, Russell H.; Gershwin, M. Eric.

In: Hepatology, Vol. 24, No. 5, 11.1996, p. 1079-1084.

Research output: Contribution to journalArticle

Van de Water, Judith A ; Gerson, Lauren B. ; Ferrell, Linda D. ; Lake, John R. ; Coppel, Ross L. ; Batts, Kenneth P. ; Wiesner, Russell H. ; Gershwin, M. Eric. / Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. In: Hepatology. 1996 ; Vol. 24, No. 5. pp. 1079-1084.
@article{da76267377b94444895f80826bc9e1ac,
title = "Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis",
abstract = "Whether primary biliary cirrhosis (PBC) recurs after liver transplantation has remained an interesting and controversial issue; rejection, viral hepatitis, and drug effects all may mimic recurrent PBC histologically and biochemically. Furthermore, reliable clinical criteria for PBC recurrence are lacking. In this study, the issue of disease recurrence using a well-characterized monoclonal antibody (MAb), C355.1, that reacts with the immunodominant mitochondrial autoantigen of PBC (pyruvate dehydrogenase complex [PDC-E2]) was addressed. When used in an immunohistochemical assay, C355.1 produces intense apical staining of bile duct epithelium specifically in liver sections of patients with PBC and may be the earliest known marker of PBC. Immunohistochemical and histological analysis of serial liver biopsy specimens of 67 patients pre- and post- orthotopic liver transplantation (OLT), including 38 patients with PBC and 29 non-PBC liver disease controls, was performed. Sections were stained with MAb C355.1 or the control MAb C315 and analyzed to determine whether there was a recurrence of apical reactivity in the bile ducts of the posttransplantation biopsy specimens. The immunohistochemical staining was correlated with the histological findings and serum biochemistries at the time of the biopsy. Our data indicate that a significant number of patients who underwent transplantation for PBC (28 of 38) but not controls (0 of 29) develop a staining pattern of liver bile duct epithelium with MAb C355.1 that is indistinguishable from the pretransplantation pattern. Of the 28 patients with this apical staining pattern, 8 were characterized histologically as possible recurrent PBC, 2 as chronic rejection, 2 as acute rejection, 9 as nonspecific changes, 4 as normal or near normal, and 3 had other histological changes. Only 50{\%} of the patients with apical C355.1 staining had liver enzyme levels suggestive of cholestasis. Thus, there appears to be immunohistochemical evidence that supports the concept of recurrence of PBC after OLT. The appearance of biliary epithelial abnormalities before the clinical appearance of disease is important not only for liver transplantation but also for understanding the natural history of PBC.",
author = "{Van de Water}, {Judith A} and Gerson, {Lauren B.} and Ferrell, {Linda D.} and Lake, {John R.} and Coppel, {Ross L.} and Batts, {Kenneth P.} and Wiesner, {Russell H.} and Gershwin, {M. Eric}",
year = "1996",
month = "11",
doi = "10.1053/jhep.1996.v24.pm0008903379",
language = "English (US)",
volume = "24",
pages = "1079--1084",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis

AU - Van de Water, Judith A

AU - Gerson, Lauren B.

AU - Ferrell, Linda D.

AU - Lake, John R.

AU - Coppel, Ross L.

AU - Batts, Kenneth P.

AU - Wiesner, Russell H.

AU - Gershwin, M. Eric

PY - 1996/11

Y1 - 1996/11

N2 - Whether primary biliary cirrhosis (PBC) recurs after liver transplantation has remained an interesting and controversial issue; rejection, viral hepatitis, and drug effects all may mimic recurrent PBC histologically and biochemically. Furthermore, reliable clinical criteria for PBC recurrence are lacking. In this study, the issue of disease recurrence using a well-characterized monoclonal antibody (MAb), C355.1, that reacts with the immunodominant mitochondrial autoantigen of PBC (pyruvate dehydrogenase complex [PDC-E2]) was addressed. When used in an immunohistochemical assay, C355.1 produces intense apical staining of bile duct epithelium specifically in liver sections of patients with PBC and may be the earliest known marker of PBC. Immunohistochemical and histological analysis of serial liver biopsy specimens of 67 patients pre- and post- orthotopic liver transplantation (OLT), including 38 patients with PBC and 29 non-PBC liver disease controls, was performed. Sections were stained with MAb C355.1 or the control MAb C315 and analyzed to determine whether there was a recurrence of apical reactivity in the bile ducts of the posttransplantation biopsy specimens. The immunohistochemical staining was correlated with the histological findings and serum biochemistries at the time of the biopsy. Our data indicate that a significant number of patients who underwent transplantation for PBC (28 of 38) but not controls (0 of 29) develop a staining pattern of liver bile duct epithelium with MAb C355.1 that is indistinguishable from the pretransplantation pattern. Of the 28 patients with this apical staining pattern, 8 were characterized histologically as possible recurrent PBC, 2 as chronic rejection, 2 as acute rejection, 9 as nonspecific changes, 4 as normal or near normal, and 3 had other histological changes. Only 50% of the patients with apical C355.1 staining had liver enzyme levels suggestive of cholestasis. Thus, there appears to be immunohistochemical evidence that supports the concept of recurrence of PBC after OLT. The appearance of biliary epithelial abnormalities before the clinical appearance of disease is important not only for liver transplantation but also for understanding the natural history of PBC.

AB - Whether primary biliary cirrhosis (PBC) recurs after liver transplantation has remained an interesting and controversial issue; rejection, viral hepatitis, and drug effects all may mimic recurrent PBC histologically and biochemically. Furthermore, reliable clinical criteria for PBC recurrence are lacking. In this study, the issue of disease recurrence using a well-characterized monoclonal antibody (MAb), C355.1, that reacts with the immunodominant mitochondrial autoantigen of PBC (pyruvate dehydrogenase complex [PDC-E2]) was addressed. When used in an immunohistochemical assay, C355.1 produces intense apical staining of bile duct epithelium specifically in liver sections of patients with PBC and may be the earliest known marker of PBC. Immunohistochemical and histological analysis of serial liver biopsy specimens of 67 patients pre- and post- orthotopic liver transplantation (OLT), including 38 patients with PBC and 29 non-PBC liver disease controls, was performed. Sections were stained with MAb C355.1 or the control MAb C315 and analyzed to determine whether there was a recurrence of apical reactivity in the bile ducts of the posttransplantation biopsy specimens. The immunohistochemical staining was correlated with the histological findings and serum biochemistries at the time of the biopsy. Our data indicate that a significant number of patients who underwent transplantation for PBC (28 of 38) but not controls (0 of 29) develop a staining pattern of liver bile duct epithelium with MAb C355.1 that is indistinguishable from the pretransplantation pattern. Of the 28 patients with this apical staining pattern, 8 were characterized histologically as possible recurrent PBC, 2 as chronic rejection, 2 as acute rejection, 9 as nonspecific changes, 4 as normal or near normal, and 3 had other histological changes. Only 50% of the patients with apical C355.1 staining had liver enzyme levels suggestive of cholestasis. Thus, there appears to be immunohistochemical evidence that supports the concept of recurrence of PBC after OLT. The appearance of biliary epithelial abnormalities before the clinical appearance of disease is important not only for liver transplantation but also for understanding the natural history of PBC.

UR - http://www.scopus.com/inward/record.url?scp=0029858363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029858363&partnerID=8YFLogxK

U2 - 10.1053/jhep.1996.v24.pm0008903379

DO - 10.1053/jhep.1996.v24.pm0008903379

M3 - Article

VL - 24

SP - 1079

EP - 1084

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -